EPIRUS Biopharmaceuticals, Inc. Payments for Restructuring
EPIRUS Biopharmaceuticals, Inc. reported Payments for Restructuring of $34.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2014-03-14
- EPIRUS Biopharmaceuticals, Inc. payments for restructuring for fiscal 2013 was $34.00K, a 96.81% decline from fiscal 2012.
- EPIRUS Biopharmaceuticals, Inc. payments for restructuring for fiscal 2012 was $1.07M.
| Period end | Payments for Restructuring 12 month |
|---|---|
| 2013-12-31 | $34.00K 10-K · filed 2014-03-14 |
| 2012-12-31 | $1.07M 10-K · filed 2014-03-14 |